Opsumit for long-term treatment of pulmonary arterial hypertensionNew oral endothelin receptor antagonist is effective alone or with a phosphodiesterase-5 inhibitor. Anticoagulants good for brain Smallest first-in-human pacemaker implanted Statin adverse effects and intolerance Canadian Working Group provides update on diagnosis, prevention, and management Is the new sodium guideline worth its salt? Amid debate over the optimal intake, hypertension experts raise the daily upper limit Terror worries may slow progress in medical devices Physicians say ‘chill’ is affecting manufacturers New U.S. cardiac guidelines cause a ruckus Canadian experts deliver their takes on LDL targets and risk assessment Adempas for chronic thromboembolic pulmonary hypertension First drug approved to treat rare type of pulmonary hypertension. MIs differ in younger women Simple survey in the pharmacy could help heart failure patients Pilot program shows pharmacists could do more in disease management and detection First Previous 47 48 49 50 51 Next Last
